ARTICLE SUMMARY:
Should generative AI tools be trained, evaluated, and monitored like doctors as an alternative to regulatory oversight? The proposed RAPID pathway: designing pivotal trials that will address regulatory authorization and national Medicare coverage. The global shift from passive filing to active mining of postmarket surveillance data to identify industry trends. CMS proposes to end fast track to extra Medicare payments for breakthrough devices used in some hospital settings.
